Prehabilitation During Neoadjuvant Chemotherapy Results In An Enhanced Tumour Immune Response In Oesophageal Cancer

被引：0
|
作者：
Bartlett, David B. [1 ]
Rayner, Charles [1 ]
Woolridge, Tyler [1 ]
Seymour, Tadd [1 ]
Allen, Sophie [2 ]
Sunshine, Sunny [1 ]
Hunt, Julie [1 ]
King, David [1 ]
Bagwan, Izhar [2 ]
Frampton, Adam [1 ]
Abbassi-Ghadi, Nima [2 ]
Annels, Nicola E. [1 ]
机构：
[1] Univ Surrey, Guildford, Surrey, England
[2] Royal Surrey NHS Fdn Trust, Guildford, Surrey, England
来源：
MEDICINE & SCIENCE IN SPORTS & EXERCISE | 2024年 / 56卷 / 10期
关键词：
D O I：
暂无
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
2960
引用
收藏
页码：1092 / 1092
页数：1
相关论文
共 50 条
  • [31] Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
    Daiki Ikarashi
    Shigehisa Kitano
    Takashi Tsuyukubo
    Kazumasa Takenouchi
    Takayuki Nakayama
    Hiroko Onagi
    Asumi Sakaguchi
    Makiko Yamashita
    Hidenori Mizugaki
    Shigekatsu Maekawa
    Renpei Kato
    Yoichiro Kato
    Tamotsu Sugai
    Tetsuya Nakatsura
    Wataru Obara
    British Journal of Cancer, 2022, 126 : 606 - 614
  • [32] Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
    Ikarashi, Daiki
    Kitano, Shigehisa
    Tsuyukubo, Takashi
    Takenouchi, Kazumasa
    Nakayama, Takayuki
    Onagi, Hiroko
    Sakaguchi, Asumi
    Yamashita, Makiko
    Mizugaki, Hidenori
    Maekawa, Shigekatsu
    Kato, Renpei
    Kato, Yoichiro
    Sugai, Tamotsu
    Nakatsura, Tetsuya
    Obara, Wataru
    BRITISH JOURNAL OF CANCER, 2022, 126 (04) : 606 - 614
  • [33] The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy
    Nakajo, M.
    Kitajima, K.
    Kaida, H.
    Morita, T.
    Minamimoto, R.
    Ishibashi, M.
    Yoshiura, T.
    CLINICAL RADIOLOGY, 2020, 75 (01) : 79.e9 - 79.e18
  • [34] Prehabilitation for Patients With Esophageal Cancer During Neoadjuvant Treatment and Surgery
    Hennessy, Mairead
    Spartalis, Eleftherios
    Athanasiou, Antonios
    JOURNAL OF SURGICAL RESEARCH, 2019, 242 : 1 - 2
  • [35] WHAT IS THE OPTIMAL NEOADJUVANT CHEMOTHERAPY REGIMEN IN RESECTABLE OESOPHAGEAL CANCER?
    Chau, Ian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 77 - 77
  • [36] Interpretation of contrast enhanced MRI for early prediction of breast-cancer response to neoadjuvant chemotherapy: Initial results
    Loo, C. E.
    Teertstra, H. J.
    Rodenhuis, S.
    de Vijver, M. J. Van
    Hannemann, J.
    Muller, S. H.
    Peeters, M. J. Vrancken
    Gilhuijs, K. G. A.
    EJC SUPPLEMENTS, 2008, 6 (07): : 112 - 112
  • [37] Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
    Goto, Wataru
    Kashiwagi, Shinichiro
    Asano, Yuka
    Takada, Koji
    Takahashi, Katsuyuki
    Hatano, Takaharu
    Takashima, Tsutomu
    Tomita, Shuhei
    Motomura, Hisashi
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    ESMO OPEN, 2018, 3 (06)
  • [38] Does metabolic response at repeat PET/CT examination predict pathological response to neoadjuvant chemotherapy in oesophageal cancer?
    Gillies, R. S.
    Middleton, M. R.
    Warren, B.
    Bradley, K. M.
    Gleeson, F. V.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 7 - 7
  • [39] Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy
    Gabriel, Emmanuel M.
    Sukniam, Kulkaew
    Popp, Kyle
    Kowkabany, Gabrielle
    Manaise, Harsheen K.
    Attwood, Kristopher
    George, Anthony
    Zhai, Qihui
    Bagaria, Sanjay P.
    Knutson, Keith L.
    Skitzki, Joseph J.
    Robertson, Matthew W.
    Dinh, Tri A.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (04):
  • [40] Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
    Moore, Jonathan
    Subesinghe, Manil
    Santaolalla, Aida
    Green, Michael
    Deere, Harriet
    Van Hemelrijck, Mieke
    Lagergren, Jesper
    Chicklore, Sugama
    Maisey, Nick
    Gossage, James
    Kelly, Mark
    Baker, Cara
    Davies, Andrew
    EUROPEAN RADIOLOGY, 2023, 33 (05) : 3647 - 3659
12345